プラスミドDNA製造の世界市場レポート 2025年

プラスミドDNA製造市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR23.6％で67億8,000万米ドルに成長します。予測期間の成長は、感染症用DNAワクチンの開発におけるプラスミドDNAの使用の増加、抗体薬物複合体の開発におけるプラスミドDNAの採用の増加、個別化治療、がん治療法の開発におけるプラスミドDNAの使用、知的財産の開発などに起因すると考えられます。予測期間における主な動向としては、プラスミドDNA技術のライセンス契約の活発化、カスタマイズされたソリューション、コスト削減戦略、ハイスループットスクリーニング、スケーラブルな製造ソリューションの開発などが挙げられます。

遺伝子治療の採用が増加していることが、今後のプラスミドDNA製造市場の拡大を牽引する見通しです。遺伝子治療は、病気の治療や予防のために遺伝子の修正や操作を伴う医療アプローチであり、遺伝子工学技術の進歩、研究開発への投資の増加、臨床試験の成功、遺伝性疾患の発生率の上昇などにより、支持を集めています。これらの要因は、長期的あるいは恒久的な治療法を提供する可能性を強調しています。プラスミドDNA製造は、治療遺伝子を細胞内に導入するのに必要なベクターを製造し、遺伝性疾患の治療を促進するため、遺伝子治療において重要な役割を果たしています。例えば、American Society of Gene &Cell Therapyのデータでは、2023年第3四半期に第III相臨床試験中の遺伝子治療薬の数が10％増加し、2022年第3四半期以来四半期ベースで初めて増加したことが明らかになっています。このように、遺伝子治療の受け入れ拡大がプラスミドDNA製造市場の成長を後押ししています。

プラスミドDNA製造市場の主なプレーヤーは、プラスミドDNA生産の効率性、拡張性、品質を高めるための高度なバイオプロセス技術の開発に注力しています。これらの技術的進歩は、製造プロセスを合理化し、製造コストを削減し、治療用途の厳しい規制基準へのコンプライアンスを確保することを目的としています。例えば、米国の製薬会社チャールズ・リバー・ラボラトリーズは、2023年1月にeXpDNAプラットフォームを発表しました。このプラットフォームは、高度なバイオプロセス技術、スケーラブルな生産方法、厳格な品質管理対策を統合し、治療や臨床応用に適した高品質のプラスミドDNAを提供します。遺伝子治療、DNAワクチン開発、その他のバイオ医薬品用途に広く利用されているeXpDNAプラットフォームは、高い収率、純度、一貫性を保証します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界プラスミドDNA製造PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のプラスミドDNA製造市場：成長率分析
• 世界のプラスミドDNA製造市場の実績：規模と成長, 2019-2024
• 世界のプラスミドDNA製造市場の予測：規模と成長, 2024-2029, 2034F
• 世界プラスミドDNA製造総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のプラスミドDNA製造市場：グレード別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 研究開発グレード
• 適正製造規範（GMP）グレード
• 世界のプラスミドDNA製造市場開発フェーズ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 前臨床治療
• 臨床治療学
• 市販治療薬
• 世界のプラスミドDNA製造市場：疾患別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染症
• がん
• 遺伝性疾患
• その他の病気
• 世界のプラスミドDNA製造市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• デオキシリボ核酸（DNA）ワクチン
• 細胞および遺伝子治療
• 免疫療法
• その他の用途
• 世界のプラスミドDNA製造市場研究開発グレードのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小規模プラスミドDNA生産
• 前臨床調査用プラスミドDNA
• 世界のプラスミドDNA製造市場、適正製造基準（GMP）グレードのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 臨床試験材料の製造
• 商業規模のプラスミドDNA生産

第7章 地域別・国別分析

• 世界のプラスミドDNA製造市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のプラスミドDNA製造市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• プラスミドDNA製造市場：競合情勢
• プラスミドDNA製造市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Genomics LLC Overview, Products and Services, Strategy and Financial Analysis
  • Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Recipharm AB Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Kaneka Corp.
• Genscript Biotech Corporation
• Aldevron LLC
• Genewiz
• OriGene Technologies
• Celonic AG
• Creative Biogene
• Cellectis
• Synbio Technologies
• VectorBuilder Inc.
• Altogen Biosystems
• Addgene
• Andelyn Biosciences
• AGC Biologics
• VGXI

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• プラスミドDNA製造市場2029：新たな機会を提供する国
• プラスミドDNA製造市場2029：新たな機会を提供するセグメント
• プラスミドDNA製造市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Plasmid deoxyribonucleic acid (DNA) manufacturing involves producing large quantities of plasmid DNA molecules for various biotechnological applications, including gene therapy, molecular cloning, and recombinant protein production. This process entails cultivating bacterial cells containing the desired plasmid DNA, followed by purification to isolate the plasmid DNA from other cellular components.

The primary grades of plasmid DNA manufacturing include research and development grade, and good manufacturing practice (GMP) grade. Research and Development grade plasmid DNA is primarily intended for laboratory research and early-stage development processes. It is utilized across various development phases such as pre-clinical therapeutics, clinical therapeutics, and marketed therapeutics for treating infectious diseases, cancer, genetic disorders, and other ailments. This type of DNA is essential for various applications including DNA vaccines, cell and gene therapy, immunotherapy, and others.

The plasmid DNA manufacturing market research report is one of a series of new reports from The Business Research Company that provides plasmid DNA manufacturing market statistics, including the plasmid DNA manufacturing industry global market size, regional shares, competitors with plasmid DNA manufacturing market share, detailed plasmid DNA manufacturing market segments, market trends, and opportunities, and any further data you may need to thrive in the plasmid DNA manufacturing industry. This plasmid DNA manufacturing market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The plasmid DNA manufacturing market size has grown exponentially in recent years. It will grow from $2.34 billion in 2024 to $2.9 billion in 2025 at a compound annual growth rate (CAGR) of 23.9%. The growth in the historic period can be attributed to the application of plasmid DNA in industrial processes, the use of plasmid DNA in creating genetically modified organisms, the production of monoclonal antibodies using plasmid DNA in cell lines, international health initiatives, plasmid DNA is used in bioremediation and other environmental applications and microbiome studies.

The plasmid DNA manufacturing market size is expected to see exponential growth in the next few years. It will grow to $6.78 billion in 2029 at a compound annual growth rate (CAGR) of 23.6%. The growth in the forecast period can be attributed to the increasing use of plasmid DNA in the development of DNA vaccines for infectious diseases, increasing adoption of plasmid DNA in the development of antibody-drug conjugates, personalized therapies, the use of plasmid DNA in developing cancer treatments and intellectual property developments. Major trends in the forecast period include increasing activity in licensing agreements for plasmid DNA technologies, customized solutions, cost reduction strategies, high-throughput screening, and the development of scalable manufacturing solutions.

The increasing adoption of gene therapy is poised to drive the expansion of the plasmid DNA manufacturing market in the future. Gene therapy, a medical approach involving the modification or manipulation of genes to treat or prevent diseases, is gaining traction due to advancements in genetic engineering technologies, augmented investment in research and development, successful clinical trials, and the rising incidence of genetic disorders. These factors underscore its potential to offer long-lasting or permanent remedies. Plasmid DNA manufacturing plays a crucial role in gene therapy as it produces the vectors necessary to deliver therapeutic genes into cells, facilitating the treatment of genetic disorders. For instance, data from the American Society of Gene & Cell Therapy reveals a 10% increase in the number of gene therapies in Phase III clinical trials during Q3 2023, marking the first quarterly uptick since Q3 2022. Thus, the growing acceptance of gene therapy is fueling the growth of the plasmid DNA manufacturing market.

Key players in the plasmid DNA manufacturing market are focusing on the development of advanced bioprocessing technologies to enhance the efficiency, scalability, and quality of plasmid DNA production. These technological advancements aim to streamline manufacturing processes, reduce production costs, and ensure compliance with stringent regulatory standards for therapeutic applications. For example, Charles River Laboratories, a US-based pharmaceutical company, introduced the eXpDNA platform in January 2023. This platform integrates advanced bioprocessing technologies, scalable production methods, and stringent quality control measures to deliver high-quality plasmid DNA suitable for therapeutic and clinical applications. Widely utilized in gene therapy, DNA vaccine development, and other biopharmaceutical applications, the eXpDNA platform ensures high yield, purity, and consistency.

In December 2022, Polyplus, a biotechnology company based in France that specializes in developing products and technologies for biopharmaceutical production, acquired Xpress Biologics for an undisclosed sum. This acquisition is intended to strengthen Polyplus's product offerings, broaden its capabilities in the biotechnology field, and expedite the development of innovative solutions for biopharmaceutical production. Xpress Biologics, a biotechnology company located in Belgium, focuses on the development and manufacturing of biologics, with an emphasis on therapeutic proteins and monoclonal antibodies.

Major companies operating in the plasmid dna manufacturing market are Thermo Fisher Scientific Inc., Eurofins Genomics LLC, Catalent Inc., Charles River Laboratories, Recipharm AB, Kaneka Corp., Genscript Biotech Corporation, Aldevron LLC, Genewiz, OriGene Technologies, Celonic AG, Creative Biogene, Cellectis, Synbio Technologies, VectorBuilder Inc., Altogen Biosystems, Addgene, Andelyn Biosciences, AGC Biologics, VGXI, BioCat GmbH, GeneCopoeia, PlasmidFactory GmbH & Co. KG, Akron Biotech, PackGene Biotech lnc.

North America was the largest region in the plasmid DNA manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasmid dna manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the plasmid dna manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The plasmid DNA manufacturing market consists of revenues earned by entities by providing services such as plasmid design, construction, production, purification, quality control, customization, storage, shipping, and regulatory support. The market value includes the value of related goods sold by the service provider or included within the service offering. The plasmid DNA manufacturing market also includes sales of bioreactors, centrifuges, incubators, chromatography systems, freeze dryers, electrophoresis systems, and microscopes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plasmid DNA Manufacturing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on plasmid dna manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plasmid dna manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The plasmid dna manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Grade: Research And Development Grade; Good Manufacturing Practice (GMP) Grade
• 2) By Development Phase: Pre-Clinical Therapeutics; Clinical Therapeutics; Marketed Therapeutics
• 3) By Disease: Infectious Disease; Cancer; Genetic Disorder; Other Diseases
• 4) By Application: Deoxyribonucleic Acid (DNA) Vaccines; Cell And Gene Therapy; Immunotherapy; Other Applications
• Subsegments:
• 1) By Research And Development Grade: Small-scale Plasmid DNA Production; Preclinical Research Plasmid DNA
• 2) By Good Manufacturing Practice (GMP) Grade: Clinical Trial Material Production; Commercial-Scale Plasmid DNA Production
• Companies Mentioned: Thermo Fisher Scientific Inc.; Eurofins Genomics LLC; Catalent Inc.; Charles River Laboratories; Recipharm AB
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Plasmid DNA Manufacturing Market Characteristics

3. Plasmid DNA Manufacturing Market Trends And Strategies

4. Plasmid DNA Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Plasmid DNA Manufacturing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Plasmid DNA Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Plasmid DNA Manufacturing Market Growth Rate Analysis
• 5.4. Global Plasmid DNA Manufacturing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Plasmid DNA Manufacturing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Plasmid DNA Manufacturing Total Addressable Market (TAM)

6. Plasmid DNA Manufacturing Market Segmentation

• 6.1. Global Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research And Development Grade
• Good Manufacturing Practice (GMP) Grade
• 6.2. Global Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-Clinical Therapeutics
• Clinical Therapeutics
• Marketed Therapeutics
• 6.3. Global Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Disease
• Cancer
• Genetic Disorder
• Other Diseases
• 6.4. Global Plasmid DNA Manufacturing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Deoxyribonucleic Acid (DNA) Vaccines
• Cell And Gene Therapy
• Immunotherapy
• Other Applications
• 6.5. Global Plasmid DNA Manufacturing Market, Sub-Segmentation Of Research And Development Grade, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small-scale Plasmid DNA Production
• Preclinical Research Plasmid DNA
• 6.6. Global Plasmid DNA Manufacturing Market, Sub-Segmentation Of Good Manufacturing Practice (GMP) Grade, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Trial Material Production
• Commercial-Scale Plasmid DNA Production

7. Plasmid DNA Manufacturing Market Regional And Country Analysis

• 7.1. Global Plasmid DNA Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Plasmid DNA Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Plasmid DNA Manufacturing Market

• 8.1. Asia-Pacific Plasmid DNA Manufacturing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Plasmid DNA Manufacturing Market

• 9.1. China Plasmid DNA Manufacturing Market Overview
• 9.2. China Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Plasmid DNA Manufacturing Market

• 10.1. India Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Plasmid DNA Manufacturing Market

• 11.1. Japan Plasmid DNA Manufacturing Market Overview
• 11.2. Japan Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Plasmid DNA Manufacturing Market

• 12.1. Australia Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Plasmid DNA Manufacturing Market

• 13.1. Indonesia Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Plasmid DNA Manufacturing Market

• 14.1. South Korea Plasmid DNA Manufacturing Market Overview
• 14.2. South Korea Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Plasmid DNA Manufacturing Market

• 15.1. Western Europe Plasmid DNA Manufacturing Market Overview
• 15.2. Western Europe Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Plasmid DNA Manufacturing Market

• 16.1. UK Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Plasmid DNA Manufacturing Market

• 17.1. Germany Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Plasmid DNA Manufacturing Market

• 18.1. France Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Plasmid DNA Manufacturing Market

• 19.1. Italy Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Plasmid DNA Manufacturing Market

• 20.1. Spain Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Plasmid DNA Manufacturing Market

• 21.1. Eastern Europe Plasmid DNA Manufacturing Market Overview
• 21.2. Eastern Europe Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Plasmid DNA Manufacturing Market

• 22.1. Russia Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Plasmid DNA Manufacturing Market

• 23.1. North America Plasmid DNA Manufacturing Market Overview
• 23.2. North America Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Plasmid DNA Manufacturing Market

• 24.1. USA Plasmid DNA Manufacturing Market Overview
• 24.2. USA Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Plasmid DNA Manufacturing Market

• 25.1. Canada Plasmid DNA Manufacturing Market Overview
• 25.2. Canada Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Plasmid DNA Manufacturing Market

• 26.1. South America Plasmid DNA Manufacturing Market Overview
• 26.2. South America Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Plasmid DNA Manufacturing Market

• 27.1. Brazil Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Plasmid DNA Manufacturing Market

• 28.1. Middle East Plasmid DNA Manufacturing Market Overview
• 28.2. Middle East Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Plasmid DNA Manufacturing Market

• 29.1. Africa Plasmid DNA Manufacturing Market Overview
• 29.2. Africa Plasmid DNA Manufacturing Market, Segmentation By Grade, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Plasmid DNA Manufacturing Market, Segmentation By Development Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Plasmid DNA Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Plasmid DNA Manufacturing Market Competitive Landscape And Company Profiles

• 30.1. Plasmid DNA Manufacturing Market Competitive Landscape
• 30.2. Plasmid DNA Manufacturing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Eurofins Genomics LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Recipharm AB Overview, Products and Services, Strategy and Financial Analysis

31. Plasmid DNA Manufacturing Market Other Major And Innovative Companies

• 31.1. Kaneka Corp.
• 31.2. Genscript Biotech Corporation
• 31.3. Aldevron LLC
• 31.4. Genewiz
• 31.5. OriGene Technologies
• 31.6. Celonic AG
• 31.7. Creative Biogene
• 31.8. Cellectis
• 31.9. Synbio Technologies
• 31.10. VectorBuilder Inc.
• 31.11. Altogen Biosystems
• 31.12. Addgene
• 31.13. Andelyn Biosciences
• 31.14. AGC Biologics
• 31.15. VGXI

32. Global Plasmid DNA Manufacturing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Plasmid DNA Manufacturing Market

34. Recent Developments In The Plasmid DNA Manufacturing Market

35. Plasmid DNA Manufacturing Market High Potential Countries, Segments and Strategies

• 35.1 Plasmid DNA Manufacturing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Plasmid DNA Manufacturing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Plasmid DNA Manufacturing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer